https://www.selleckchem.com/pr....oducts/act001-dmamcl
Alcoholic hepatitis (AH) is characterized by acute liver failure, neurocognitive impairment and renal failure. Severe inflammatory reactions are also known to occur in AH. Inflammation and bacterial translocation in the gut are thought to have major impact on disease development and progression. The mortality rate for AH is close to 50%. We aimed to assess the efficacy of rifaximin in treating AH and its impact on inflammation and metabolism. The trial was approved by relevant authorities (EudraCT no 2014-02264-33, Scientific Ethi
Like
Comment
Share
